These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 21476974)
1. Lipoprotein(a): medical treatment options for an elusive molecule. Parhofer KG Curr Pharm Des; 2011; 17(9):871-6. PubMed ID: 21476974 [TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of and treatment options for increased lipoprotein(a)]. Zsíros N; Paragh G; Harangi M Orv Hetil; 2014 Apr; 155(16):607-14. PubMed ID: 24733102 [TBL] [Abstract][Full Text] [Related]
3. Latest developments in the treatment of lipoprotein (a). Bos S; Yayha R; van Lennep JE Curr Opin Lipidol; 2014 Dec; 25(6):452-60. PubMed ID: 25318824 [TBL] [Abstract][Full Text] [Related]
4. Increased cardiovascular risk associated with hyperlipoproteinemia (a) and the challenges of current and future therapeutic possibilities. Fras Z Anatol J Cardiol; 2020 Jan; 23(2):60-69. PubMed ID: 32011323 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options. Anagnostis P; Karras S; Lambrinoudaki I; Stevenson JC; Goulis DG Int J Clin Pract; 2016 Dec; 70(12):967-977. PubMed ID: 28032426 [TBL] [Abstract][Full Text] [Related]
6. What are we able to achieve today for our patients with homozygous familial hypercholesterolaemia, and what are the unmet needs? Santos RD Atheroscler Suppl; 2014 Sep; 15(2):19-25. PubMed ID: 25257073 [TBL] [Abstract][Full Text] [Related]
7. AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial. Desai NR; Kohli P; Giugliano RP; O'Donoghue ML; Somaratne R; Zhou J; Hoffman EB; Huang F; Rogers WJ; Wasserman SM; Scott R; Sabatine MS Circulation; 2013 Aug; 128(9):962-9. PubMed ID: 23884353 [TBL] [Abstract][Full Text] [Related]
8. [Position of lipoprotein apheresis in present]. Bláha V; Bláha M; Lánská M; Havel E; Vyroubal P; Zadák Z; Vrablík M; Piťha J; Žák P; Sobotka L Vnitr Lek; 2015 Nov; 61(11):958-64. PubMed ID: 26652784 [TBL] [Abstract][Full Text] [Related]
19. Niacin as a component of combination therapy for dyslipidemia. Miller M Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785 [TBL] [Abstract][Full Text] [Related]